These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6820682)

  • 1. [Antigenic structures, virulence factors, immunity, vaccination and chemoprophylaxis of Meningococci].
    Berkman E
    Mikrobiyol Bul; 1982; 16(4):297-302. PubMed ID: 6820682
    [No Abstract]   [Full Text] [Related]  

  • 2. Meningococcal vaccines in prevention and control of meningitis.
    Saxena SN; Rawal IJ; Tripathi KK; Gupta P
    Indian Pediatr; 1985 Jun; 22(6):453-65. PubMed ID: 3938978
    [No Abstract]   [Full Text] [Related]  

  • 3. Susceptibility to meningococcal meningitis.
    Sabath LD; Rosner B
    N Engl J Med; 1973 May; 288(22):1185. PubMed ID: 4633552
    [No Abstract]   [Full Text] [Related]  

  • 4. [Changes in the antigenic properties of strains of Neisseria meningitidis isolated from the cerebrospinal fluid of patients with meningitis].
    Kuzemenská P
    Cesk Epidemiol Mikrobiol Imunol; 1985 Mar; 34(2):91-9. PubMed ID: 3157468
    [No Abstract]   [Full Text] [Related]  

  • 5. Right age for Meningococcal vaccine.
    John TJ
    Indian Pediatr; 1998 Jul; 35(7):669-70. PubMed ID: 10216680
    [No Abstract]   [Full Text] [Related]  

  • 6. Recognition of Neisseria meningitidis by the long pentraxin PTX3 and its role as an endogenous adjuvant.
    Bottazzi B; Santini L; Savino S; Giuliani MM; Dueñas Díez AI; Mancuso G; Beninati C; Sironi M; Valentino S; Deban L; Garlanda C; Teti G; Pizza M; Rappuoli R; Mantovani A
    PLoS One; 2015; 10(3):e0120807. PubMed ID: 25786110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meningitis vaccination in Auckland.
    Newman J
    N Z Med J; 1987 Oct; 100(833):636. PubMed ID: 3132658
    [No Abstract]   [Full Text] [Related]  

  • 8. [Induction of anti-meningitis immunity using the synthetic peptides. I. The immunoreactive synthetic fragments of porin A from Neisseria meningitidis].
    Koroev DO; Kotel'nikova OV; Vol'pina OM; Zhmak MN; Kupriianova MA; Agafonova SA; Alliluev AP; Litvinov IS; Nesmeianov VA; Ivanov VT
    Bioorg Khim; 2000 May; 26(5):323-9. PubMed ID: 10900502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiology. A furtive pathogen revealed.
    Nassif X
    Science; 2000 Mar; 287(5459):1767-8. PubMed ID: 10755929
    [No Abstract]   [Full Text] [Related]  

  • 10. Demonstration of lipooligosaccharide immunotype and capsule as virulence factors for Neisseria meningitidis using an infant mouse intranasal infection model.
    Mackinnon FG; Borrow R; Gorringe AR; Fox AJ; Jones DM; Robinson A
    Microb Pathog; 1993 Nov; 15(5):359-66. PubMed ID: 7912406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal immunity and optimizing protection with meningococcal serogroup B vaccines.
    Heyderman RS; Davenport V; Williams NA
    Trends Microbiol; 2006 Mar; 14(3):120-4. PubMed ID: 16469496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The antimeningococcal vaccination campaign in Cantabria, February-March 1997].
    González de Aledo Linos A
    An Esp Pediatr; 1998 Jan; 48(1):98-9. PubMed ID: 9542236
    [No Abstract]   [Full Text] [Related]  

  • 13. Bacterial meningitis. Appeal to thwart deadly outbreak.
    Vogel G
    Science; 2002 Oct; 298(5592):339. PubMed ID: 12376673
    [No Abstract]   [Full Text] [Related]  

  • 14. Neisseria meningitidis, Neisseria lactamica and Moraxella catarrhalis share cross-reactive carbohydrate antigens.
    Braun JM; Beuth J; Blackwell CC; Giersen S; Higgins PG; Tzanakaki G; Unverhau H; Weir DM
    Vaccine; 2004 Feb; 22(7):898-908. PubMed ID: 15040943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma fibrinogen levels after vaccination with a native outer membrane vesicle vaccine for Neisseria meningitidis.
    Keiser PB; Miller LB; Biggs-Cicatelli S; Zollinger WD
    Vaccine; 2009 Nov; 27(49):6809-13. PubMed ID: 19761833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An epidemic of meningococcal meningitis in the region of Savanes in Togo in 1997: research and control strategies].
    Aplogan A; Batchassi E; Yakoua Y; Croisier A; Aleki A; Schlumberger M; Molina S; Sidatt M; Kaninda AV
    Sante; 1997; 7(6):384-90. PubMed ID: 9503496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Survey on efficacy of inoculating purified polysaccharide vaccines as an emergency measure in preventing epidemic meningitis].
    Xu CH
    Zhonghua Liu Xing Bing Xue Za Zhi; 1982 Dec; 3(6):328-30. PubMed ID: 6821030
    [No Abstract]   [Full Text] [Related]  

  • 18. Development and use of meningococcal vaccines.
    Artenstein S
    Arch Roum Pathol Exp Microbiol; 1974 Jun; 33(2):127-32. PubMed ID: 4213026
    [No Abstract]   [Full Text] [Related]  

  • 19. [Neisseria meningitidis and meningitis].
    Nicolas P; Debonne JM; Martet G
    Med Trop (Mars); 1999; 59(1):68-78. PubMed ID: 10472587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemoprophylaxis in meningitis].
    Otero MC; Calvo MA; Pérez-Tamarit D; Asensi F
    Rev Esp Quimioter; 1998 Jun; 11(2):118-27. PubMed ID: 9795296
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.